These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26199312)

  • 1. Letter by Brutsaert and De Keulenaer Regarding Article, "Effects of Sildenafil on Ventricular and Vascular Function in Heart Failure With Preserved Ejection Fraction".
    Brutsaert DL; De Keulenaer GW
    Circ Heart Fail; 2015 Jul; 8(4):839. PubMed ID: 26199312
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Letter Regarding Article, “Effects of Sildenafil on Ventricular and Vascular Function in Heart Failure With Preserved Ejection Fraction”.
    Borlaug BA; Chen H; Lin G; Redfield MM; Lewis GD; Semigran MJ; McNulty SE; LeWinter M; Deswal A; Margulies KB
    Circ Heart Fail; 2015 Jul; 8(4):840. PubMed ID: 26405727
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction.
    Borlaug BA; Lewis GD; McNulty SE; Semigran MJ; LeWinter M; Chen H; Lin G; Deswal A; Margulies KB; Redfield MM
    Circ Heart Fail; 2015 May; 8(3):533-41. PubMed ID: 25782985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of right heart failure after left ventricular assist device implantation by phosphodiesterase 5 inhibitor.
    Hamdan R; Mansour H; Nassar P; Saab M
    Artif Organs; 2014 Nov; 38(11):963-7. PubMed ID: 24689700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDE 5 inhibition with udenafil improves left ventricular systolic/diastolic functions and exercise capacity in patients with chronic heart failure with reduced ejection fraction; A 12-week, randomized, double-blind, placebo-controlled trial.
    Kim KH; Kim HK; Hwang IC; Cho HJ; Je N; Kwon OM; Choi SJ; Lee SP; Kim YJ; Sohn DW
    Am Heart J; 2015 Jun; 169(6):813-822.e3. PubMed ID: 26027619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo.
    Westermann D; Becher PM; Lindner D; Savvatis K; Xia Y; Fröhlich M; Hoffmann S; Schultheiss HP; Tschöpe C
    Basic Res Cardiol; 2012 Nov; 107(6):308. PubMed ID: 23117837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.
    Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM
    Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil improves clinical and functional status of an elderly postmenopausal female with 'out of proportion' PH associated with left heart disease.
    Correale M; Totaro A; Ferraretti A; Di Biase M; Brunetti ND
    Monaldi Arch Chest Dis; 2013 Dec; 80(4):193-4. PubMed ID: 25087297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic response to sildenafil in patients with decompensated congestive heart failure can be predicted by deceleration time of transmitral flow.
    Morisawa D; Hirotani S; Sugahara M; Fukui M; Ando T; Naito Y; Mano T; Ishihara M; Masuyama T
    J Cardiovasc Pharmacol; 2015 Jan; 65(1):72-9. PubMed ID: 25264753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial.
    Hoendermis ES; Liu LC; Hummel YM; van der Meer P; de Boer RA; Berger RM; van Veldhuisen DJ; Voors AA
    Eur Heart J; 2015 Oct; 36(38):2565-73. PubMed ID: 26188003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure.
    Malhotra R; Dhakal BP; Eisman AS; Pappagianopoulos PP; Dress A; Weiner RB; Baggish AL; Semigran MJ; Lewis GD
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hemodynamics and effects of phosphodiesterase type 5 inhibition in heart failure: a meta-analysis of randomized trials.
    Hwang IC; Kim YJ; Park JB; Yoon YE; Lee SP; Kim HK; Cho GY; Sohn DW
    BMC Cardiovasc Disord; 2017 Jun; 17(1):150. PubMed ID: 28606099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic alpha-adrenoceptor blockade with trimazosin in congestive heart failure.
    Kirlin PC; Das S; Pitt B
    Int J Cardiol; 1985 May; 8(1):89-92. PubMed ID: 2987137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
    Yin J; Kukucka M; Hoffmann J; Sterner-Kock A; Burhenne J; Haefeli WE; Kuppe H; Kuebler WM
    Circ Heart Fail; 2011 Mar; 4(2):198-206. PubMed ID: 21216837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDE5 inhibitor sildenafil in the treatment of heart failure: a meta-analysis of randomized controlled trials.
    Zhuang XD; Long M; Li F; Hu X; Liao XX; Du ZM
    Int J Cardiol; 2014 Apr; 172(3):581-7. PubMed ID: 24534379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study.
    Guazzi M; Vicenzi M; Arena R; Guazzi MD
    Circulation; 2011 Jul; 124(2):164-74. PubMed ID: 21709061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilator therapy in chronic congestive heart failure.
    Schwartz AB; Chatterjee K
    Drugs; 1983 Aug; 26(2):148-73. PubMed ID: 6349967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study on sildenafil in treatment of pregnant women with pulmonary arterial hypertension].
    Sun X; Wang K; Wang W; Li B
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):414-8. PubMed ID: 25169631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium-mediated modulation of ergoreflex and improvement in exercise ventilation by acute sildenafil in heart failure patients.
    Guazzi M; Casali M; Berti F; Rossoni G; Colonna VD; Guazzi MD
    Clin Pharmacol Ther; 2008 Feb; 83(2):336-41. PubMed ID: 17653139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sildenafil for the treatment of pulmonary hypertension in children.
    Beghetti M; Wacker Bou Puigdefabregas J; Merali S
    Expert Rev Cardiovasc Ther; 2014 Oct; 12(10):1157-84. PubMed ID: 25223406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.